Woodline Partners LP Dyne Therapeutics, Inc. Transaction History

Woodline Partners LP

$17.6 Billion
Q2 2025

A detailed history of Woodline Partners LP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 574,853 shares of DYN stock, worth $13 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

574,853

Previous 574,435 0.07%

Holding current value

$13 Million

Previous $6.01 Million 8.92%

% of portfolio

0.03%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$6.81 - $14.78 $2,846 - $6,178	418 Added 0.07%	574,853 $5.47 Million
Q1 2025 May 15, 2025	BUY	$10.46 - $25.46 $4,999 - $12,169	478 Added 0.08%	574,435 $6.01 Million
Q4 2024 Feb 14, 2025	SELL	$23.56 - $35.55 $9.51 Million - $14.3 Million	-403,483 Reduced 41.28%	573,957 $13.5 Million
Q3 2024 Nov 14, 2024	SELL	$31.94 - $47.04 $8.19 Million - $12.1 Million	-256,468 Reduced 20.79%	977,440 $35.1 Million
Q2 2024 Aug 14, 2024	BUY	$23.65 - $35.63 $12.7 Million - $19.1 Million	535,981 Added 76.8%	1,233,908 $43.5 Million
Q1 2024 May 15, 2024	BUY	$13.06 - $29.18 $3.43 Million - $7.66 Million	262,401 Added 60.25%	697,927 $19.8 Million
Q4 2023 Feb 14, 2024	BUY	$6.62 - $13.64 $659,630 - $1.36 Million	99,642 Added 29.67%	435,526 $5.79 Million
Q3 2023 Nov 14, 2023	SELL	$8.6 - $12.18 $401,551 - $568,708	-46,692 Reduced 12.2%	335,884 $3.01 Million
Q2 2023 Aug 14, 2023	BUY	$8.53 - $14.28 $3.26 Million - $5.46 Million	382,576 New	382,576 $4.3 Million
Q2 2022 Aug 15, 2022	SELL	$4.36 - $10.5 $637,179 - $1.53 Million	-146,142 Reduced 17.97%	666,997 $4.58 Million
Q1 2022 May 16, 2022	BUY	$6.52 - $12.27 $1.95 Million - $3.66 Million	298,538 Added 58.01%	813,139 $7.84 Million
Q4 2021 Feb 14, 2022	BUY	$11.89 - $16.07 $3.55 Million - $4.8 Million	298,400 Added 138.02%	514,601 $6.12 Million
Q3 2021 Nov 15, 2021	SELL	$15.6 - $21.46 $96,298 - $132,472	-6,173 Reduced 2.78%	216,201 $3.51 Million
Q2 2021 Aug 16, 2021	SELL	$15.94 - $22.33 $2.55 Million - $3.58 Million	-160,119 Reduced 41.86%	222,374 $4.68 Million
Q1 2021 May 17, 2021	SELL	$14.0 - $29.3 $1.52 Million - $3.18 Million	-108,493 Reduced 22.1%	382,493 $5.94 Million
Q4 2020 Feb 16, 2021	BUY	$16.81 - $23.94 $3.77 Million - $5.37 Million	224,187 Added 84.03%	490,986 $10.3 Million
Q3 2020 Nov 16, 2020	BUY	$20.0 - $23.9 $5.34 Million - $6.38 Million	266,799 New	266,799 $5.39 Million

Others Institutions Holding DYN

# of Institutions

213

Shares Held

122M

Call Options Held

36.5K

Put Options Held

74.3K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.17B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Dyne Therapeutics, Inc. Transaction History